AstraZeneca suffers diabetes drug setback for COVID
Study provides new insights into resistance to immune checkpoint inhibitors
12 April 2021COVID-19 pandemic may have increased mental health issues within families
12 April 2021AstraZeneca suffers diabetes drug setback for COVID
British pharmaceutical giant AstraZeneca on Monday said that following a trial, its diabetes drug Farxiga was not successful in treating COVID patients at risk of severe complications.
